Transdermal technologies

Company news

19 Jun 2019

News4
Collaboration with OBJ to commercialise transdermal cannabis technologies

Little Green Pharma is pleased to announce a collaboration agreement with OBJ. Little Green Pharma and OBJ will contribute equally to the Curtin Research and Development services in Western Australia with the adaptation of the transdermal technology to deliver cannabinoid therapy transdermally, with a view to the joint ownership and commercialisation of the technology.

If the cannabinoid trials at Curtin University are successful in demonstrating that cannabinoids can effectively use OBJ’s micro-array technology:

  • this could result in one of the most advanced and effective medicinal cannabis delivery systems developed in the world, to date; and
  • the OBJ joint venture with Little Green Pharma could rapidly develop both its own products as well as licensing the technology to third parties for rapid distribution worldwide. Little Green Pharma operates from one of the few fully-licensed GMP certified medicinal cannabis manufacturing facilities in Australia.

Little Green Pharma is currently the only Australian medicinal cannabis company producing locally-grown and -manufactured GMP cannabis products for patients. Little Green Pharma cultivates locally grown medicinal cannabis from a secure facility in Western Australia and distributes its products nationally.

For the full media release and to read more about this exciting new partnership please visit: http://www.obj.com.au/wp-content/uploads/2019/06/02115462.pdf

You might also be interested in

News4

Company news

Transdermal technologies

Landmark collaboration to commercialise transdermal cannabis technologies

Jun 2019

Researcher viewing cannabis

Insights

Little Green Pharma Stands Out Amid The Crowded Cannabis Canopy

Little Green Pharma (ASX:LGP) has some genuine pioneering notches on its belt. Read the article here

May 2020

Grow room expansion

Insights

Commissioning of cultivation facility expansion complete

On-time and on budget. Read more about our expansion facility here.

Mar 2020

View all articles